Drugs giant GlaxoSmithKline predicts swine flu gold rush:

http://www.guardian.co.uk/business/2009/jul/22/glaxosmithkline-swine-flu-vaccine

Richard Wachman
guardian.co.uk, Wednesday 22 July 2009 20.28 BST
Britain's biggest pharmaceutical company is preparing to sell £3bn worth of swine flu drugs this year, it emerged today.
GlaxoSmithKline revealed its vaccine, one of the world's first, could be available by September after the UK government placed advance orders for 60m doses.
It also disclosed that international governments were stockpiling large supplies of GSK's anti-viral treatment Relenza, which can relieve swine flu symptoms.
Worldwide sales from the two drugs are expected to reach £3bn by January, but the company rejected claims it was exploiting the pandemic – stressing that profits would be much lower once development costs were taken into account.
It also said poorer nations would receive the vaccine for free with 50m doses to be donated to the World Health Organisation. More could follow, depending on demand.
The chief executive, Andrew Witty, said the company had been preparing for a pandemic for the last three-and-a-half years and had spent more than £1bn to ensure its factories could crank up production at short notice. "We don't know how big this deal is going to be, but no-one can say we aren't ready," said Witty. "We are working flat out with governments around the world to come up with a solution."